ROIV
NASDAQ · Biotechnology
Roivant Sciences Ltd
$36.13
-0.69 (-1.87%)
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Price Target
Analyst Price Target
+122.6% upside
Low Target
$62.72
Average Target
$80.43
High Target
$106.86
Current Price
$36.13
Current
$36.13
$36.13
Target
$80.43
$80.43
$62.72
$80.43 avg
$106.86
Scenario Analysis
Bear Case
$62.72
73.6%
Low target
Base Case
$80.43
+122.6%
Avg target
Bull Case
$106.86
+195.8%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$42.50
-15.0% from high
52-Week Low
$14.50
+149.2% from low
50-Day SMA
$23.00
+57.1% vs SMA
200-Day SMA
$16.34
+121.1% vs SMA
RSI (14)
76.4
Overbought
Target vs 52W High
$80.43
+89.2% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -2.8% |
| AMGN | Hold | 43 | 47% | $190.87 | -53.0% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +142.3% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -16.1% |
| REGN | Buy | 38 | 68% | $76.80 | -90.4% |
| MRNA | Hold | 30 | 37% | $149.45 | -23.3% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -65.0% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -42.9% |